A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients

Teva Branded Pharmaceutical Products R&D, Inc.0 个研究点目标入组 2,106 人开始时间: 2003年1月最近更新: 2010年10月18日

研究概览

简要总结

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

研究设计

研究类型: Observational

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment

排除标准

•unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

研究者

发起方

Teva Branded Pharmaceutical Products R&D, Inc.

申办方类型

Industry

相似试验

已完成

不适用

Lighting Intervention to Improve SleepSleep DisturbanceParkinson Disease

NCT05757414Icahn School of Medicine at Mount Sinai57

进行中（未招募）

不适用

Biomarkers in Parkinsonian SyndromesProgressive Supranuclear PalsyAtypical ParkinsonismParkinsonismMultiple System AtrophyParkinson Disease

NCT06501469Non-profit organization for scientific research in Parkinson's disease and related disorders200

已完成

不适用

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-DopaParkinson Disease

NCT00613301Boehringer Ingelheim416

已完成

不适用

Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled BreathParkinsonismParkinson's Disease

NCT01246336Rambam Health Care Campus41

Unknown

不适用

Epidemiology and Pathophysiology of Parkinsonism in the CaribbeansAtypical Parkinsonism

NCT03368300Centre Hospitalier Universitaire de Pointe-a-Pitre550